A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has announced the publication of research validating the ability of its xB3 platform to cross the intact blood-brain barrier (BBB) and its localization in a variety of brain cell types. The company said research shows that the xB3 platform can cross intact BBB and enter intracellular organelles within neurons, glia and microglia in the brain. It said the data from a study published on June 2 in the Frontiers in Neuroscience provide evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology for delivery of recombinant and chemically conjugated drug across the BBB.
Dow fails to eke out a winning day; tech struggles bog down Nasdaq
The latest set of jobless claims showed that the number of Americans filing for unemployment benefits fell below 400,000 for the first time since the start of the pandemic, while figures from payrolls operator ADP showed that 978,000 new private sector jobs were created in May, ahead of forecasts of 650,000
4:10pm: AMC traders head for the exits
The Dow closed Thursday down 23 points to 34,577. The Nasdaq fared worse, losing 142 points, 1%, to 13,615, while the S&P 500 dropped 15 points, 0.4%, to 4,193.
Helping the Dow salvage a relatively better day were Merck & Co Inc (NYSE:MRK) and Dow Inc (NYSE:DOW), both of which saw share price gains of more than 2%.
Albert Labs Inc announces C$4M financing ahead of CSE listing proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.